The U.S. Food and Drug Administration has struck a deal with pharmaceutical companies under which they would pay the agency fees for vetting their TV advertisements in exchange for speedier reviews… The FDA is expected to get more than $300 million in user fees in fiscal 2007, the last year of the current arrangement. The figure would increase by about one-third in fiscal 2008 under the proposed agreement…
Let us break this down for you:
The FDA is charging Big Pharma more to approve TV commercials faster, so drug companies can put more ads on TV faster.
Big Pharma will then pass these costs — as well as the costs of the additional commercials they will presumably now be able to broadcast — on to you, the consumer.
Can a broken system get more broken?